-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
Professor, Stanford University
-
President and Director, Fred Hutchinson Cancer Research Center
-
Professor of Molecular Biology, Rockefeller University
-
Former executive vice president of R&D, Amgen.
-
Meet All the Xconomists ›
-
Co-Founder and CEO, DNAnexus
-
Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
-
CEO and Co-Founder, Endeavor
-
Director, UCSD Division of the California Institute for Telecommunications and Information Technology
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News
|
Erin Kutz |
01/14/11 |
Boston
|
|
Resolvyx Sells Eye Drug to Celtic
|
Ryan McBride |
01/11/11 |
Boston
|
|
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News
|
Erin Kutz |
10/29/10 |
Boston
|
|
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News
|
Rebecca Zacks |
10/27/10 |
Boston
|
|
Resolvyx and Celtic Ink Dry Eye Deal
|
Ryan McBride |
10/26/10 |
Boston
|
|
Resolvyx Nails Dry Eye Trial, Gloucester Pulls in $29M, Shire Beefs Up Mass Presence, & Other Boston-Area Life Sciences News
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Biogen Idec VC Group Sees Opportunity in Tough Market, Has $100M New Allocation to Invest in Biotech Firms
|
Ryan McBride |
12/12/08 |
San Diego
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
Got Dry Eye? Take Fish Oil. Resolvyx Moves First Compound Into Human Test
|
Ryan McBride |
11/20/08 |
Boston
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
Boston
|
|
Resolvyx Pharmaceuticals Garners $4,000,000 Series B Financing
|
VentureDeal |
08/22/08 |
Boston
|
|
Retail Convergence Meets Up With Some Cash, TheStreet Takes to Geezeo, GSK Lifts a Glass to Sirtris, & More Deals News
|
Rebecca Zacks |
04/28/08 |
Boston
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
Boston
|
|
Resolvyx gets $25 Million in Financing to Turn Fish-Oil Science into New Drugs
|
Erik Mellgren |
04/22/08 |
Boston
|
|
Resolvyx Pharmaceuticals Secures $25,000,000 Series B Funding Round
|
VentureDeal |
04/22/08 |
Boston
|
|
Resolvyx Pharmaceuticals: Fish-Oil Mystery Solved, Blockbuster Drugs to Follow?
|
David Stipp |
11/30/07 |
Boston
|
|
Resolvyx Pharmaceuticals Obtains $17,000,000 Series A Financing
|
VentureDeal |
12/09/05 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.